Siddharth Sood

Siddharth Sood has extensive work experience in the fields of business development, finance, and quality assurance. Their most recent position is as an Associate Director of Business Development at Blueprint Medicines, where they began in June 2022. Prior to this, they worked as a Manager of Business Development at Biogen from June 2021 to June 2022. Siddharth also served as a Manager of Alliance & Integration Management, Strategy & Business Development at Alexion Pharmaceuticals, Inc. from July 2019 to June 2021. Additionally, Siddharth worked as a Senior Financial Analyst (Contract) at Alnylam Pharmaceuticals from December 2018 to May 2019. Siddharth also has experience as an MBA Intern in Financial Planning & Analysis at Moderna Therapeutics, a Graduate Teaching Assistant at Boston University Questrom School of Business, and an MBA Student Consultant at IQVIA. Earlier in their career, they worked as a Software Quality Engineer at Aspen Technology and a Quality Assurance Test Engineer at DEKA Research & Development. Siddharth began their professional journey as an Undergraduate Researcher at the Lovley Lab at the University of Massachusetts Amherst.

Siddharth Sood completed their Master of Business Administration (MBA) with a concentration in Health Sector Management from the Questrom School of Business, Boston University, between 2017 and 2019. Prior to that, they obtained two Bachelor of Science (BS) degrees, one in Chemical Engineering and another in Biochemistry and Molecular Biology, from the University of Massachusetts Amherst. Siddharth also holds additional certifications, including "Confronting Bias: Thriving Across Our Differences" from LinkedIn and a Lean Six Sigma Green Belt Certification from The Council for Six Sigma Certification (CSSC).